OptiPranolol

Active Ingredient(s): Metipranolol
FDA Approved: * December 29, 1989
Pharm Company: * BAUSCH AND LOMB
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

OptiPranolol Overview

Metipranolol (OptiPranolol, Betanol, Disorat, Trimepranol) is a non-selective beta blocker used in eye drops to treat glaucoma. It is rapidly metabolized into desacetylmetipranolol.[1] References ^ Maffei Facino, R.; Bertuletti, R.; Carini, M.; Tofanetti, O. (1980). "In vitro metabolism of methypranolol by rat liver". Analytical Chemistry Symposia Series. 4 (6): 217–223..mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\""...

Read more OptiPranolol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Metipranolol

Recent OptiPranolol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Metipranolol

Solution: 0.3%
Solution/drops: 0.3%, 0.30%

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Metipranolol or a similar ingredient: (1 result)

METIPRANOLOL